United States HIV Drugs Market Report 2017

February 2017 | 122 pages | ID: U7297B93E2AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of HIV Drugs

Revenue, means the sales value of HIV Drugs

This report studies sales (consumption) of HIV Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bristol-Myers Squibb
• Gilead Sciences
• GSK
• Johnson
• Merck
• AbbVie
• AstraZeneca
• Boehringer Ingelheim
• Cipla
• Daiichi Sankyo
• Emcure

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of HIV Drugs in each application, can be divided into

• Application 1
• Application 2

Contents

United States HIV Drugs Market Report 2017

1 HIV DRUGS OVERVIEW

1.1 Product Overview and Scope of HIV Drugs
1.2 Classification of HIV Drugs
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of HIV Drugs
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of HIV Drugs (2012-2022)
  1.4.1 United States HIV Drugs Sales and Growth Rate (2012-2022)
  1.4.2 United States HIV Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES HIV DRUGS COMPETITION BY MANUFACTURERS

2.1 United States HIV Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States HIV Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States HIV Drugs Average Price by Manufactures (2015 and 2016)
2.4 HIV Drugs Market Competitive Situation and Trends
  2.4.1 HIV Drugs Market Concentration Rate
  2.4.2 HIV Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HIV DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States HIV Drugs Sales and Market Share by States (2012-2017)
3.2 United States HIV Drugs Revenue and Market Share by States (2012-2017)
3.3 United States HIV Drugs Price by States (2012-2017)

4 UNITED STATES HIV DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States HIV Drugs Sales and Market Share by Type (2012-2017)
4.2 United States HIV Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States HIV Drugs Price by Type (2012-2017)
4.4 United States HIV Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HIV DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States HIV Drugs Sales and Market Share by Application (2012-2017)
5.2 United States HIV Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HIV DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Bristol-Myers Squibb
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 HIV Drugs Product Type, Application and Specification
    6.1.2.1
    6.1.2.2
  6.1.3 Bristol-Myers Squibb HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Gilead Sciences
  6.2.2 HIV Drugs Product Type, Application and Specification
    6.2.2.1
    6.2.2.2
  6.2.3 Gilead Sciences HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.2 HIV Drugs Product Type, Application and Specification
    6.3.2.1
    6.3.2.2
  6.3.3 GSK HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson
  6.4.2 HIV Drugs Product Type, Application and Specification
    6.4.2.1
    6.4.2.2
  6.4.3 Johnson HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck
  6.5.2 HIV Drugs Product Type, Application and Specification
    6.5.2.1
    6.5.2.2
  6.5.3 Merck HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AbbVie
  6.6.2 HIV Drugs Product Type, Application and Specification
    6.6.2.1
    6.6.2.2
  6.6.3 AbbVie HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 AstraZeneca
  6.7.2 HIV Drugs Product Type, Application and Specification
    6.7.2.1
    6.7.2.2
  6.7.3 AstraZeneca HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Boehringer Ingelheim
  6.8.2 HIV Drugs Product Type, Application and Specification
    6.8.2.1
    6.8.2.2
  6.8.3 Boehringer Ingelheim HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Cipla
  6.9.2 HIV Drugs Product Type, Application and Specification
    6.9.2.1
    6.9.2.2
  6.9.3 Cipla HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Daiichi Sankyo
  6.10.2 HIV Drugs Product Type, Application and Specification
    6.10.2.1
    6.10.2.2
  6.10.3 Daiichi Sankyo HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Emcure

7 HIV DRUGS MANUFACTURING COST ANALYSIS

7.1 HIV Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of HIV Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 HIV Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of HIV Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HIV DRUGS MARKET FORECAST (2017-2022)

11.1 United States HIV Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States HIV Drugs Sales Forecast by Type (2017-2022)
11.3 United States HIV Drugs Sales Forecast by Application (2017-2022)
11.4 HIV Drugs Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of HIV Drugs
Table Classification of HIV Drugs
Figure United States Sales Market Share of HIV Drugs by Type in 2015
Table Application of HIV Drugs
Figure United States Sales Market Share of HIV Drugs by Application in 2015
Figure United States HIV Drugs Sales and Growth Rate (2012-2022)
Figure United States HIV Drugs Revenue and Growth Rate (2012-2022)
Table United States HIV Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States HIV Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 HIV Drugs Sales Share by Manufacturers
Figure 2016 HIV Drugs Sales Share by Manufacturers
Table United States HIV Drugs Revenue by Manufacturers (2015 and 2016)
Table United States HIV Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States HIV Drugs Revenue Share by Manufacturers
Table 2016 United States HIV Drugs Revenue Share by Manufacturers
Table United States Market HIV Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market HIV Drugs Average Price of Key Manufacturers in 2015
Figure HIV Drugs Market Share of Top 3 Manufacturers
Figure HIV Drugs Market Share of Top 5 Manufacturers
Table United States HIV Drugs Sales by States (2012-2017)
Table United States HIV Drugs Sales Share by States (2012-2017)
Figure United States HIV Drugs Sales Market Share by States in 2015
Table United States HIV Drugs Revenue and Market Share by States (2012-2017)
Table United States HIV Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of HIV Drugs by States (2012-2017)
Table United States HIV Drugs Price by States (2012-2017)
Table United States HIV Drugs Sales by Type (2012-2017)
Table United States HIV Drugs Sales Share by Type (2012-2017)
Figure United States HIV Drugs Sales Market Share by Type in 2015
Table United States HIV Drugs Revenue and Market Share by Type (2012-2017)
Table United States HIV Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of HIV Drugs by Type (2012-2017)
Table United States HIV Drugs Price by Type (2012-2017)
Figure United States HIV Drugs Sales Growth Rate by Type (2012-2017)
Table United States HIV Drugs Sales by Application (2012-2017)
Table United States HIV Drugs Sales Market Share by Application (2012-2017)
Figure United States HIV Drugs Sales Market Share by Application in 2015
Table United States HIV Drugs Sales Growth Rate by Application (2012-2017)
Figure United States HIV Drugs Sales Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb HIV Drugs Sales Market Share (2012-2017)
Table Gilead Sciences Basic Information List
Table Gilead Sciences HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Gilead Sciences HIV Drugs Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK HIV Drugs Sales Market Share (2012-2017)
Table Johnson Basic Information List
Table Johnson HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson HIV Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck HIV Drugs Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie HIV Drugs Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca HIV Drugs Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim HIV Drugs Sales Market Share (2012-2017)
Table Cipla Basic Information List
Table Cipla HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cipla HIV Drugs Sales Market Share (2012-2017)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo HIV Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Daiichi Sankyo HIV Drugs Sales Market Share (2012-2017)
Table Emcure Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of HIV Drugs
Figure Manufacturing Process Analysis of HIV Drugs
Figure HIV Drugs Industrial Chain Analysis
Table Raw Materials Sources of HIV Drugs Major Manufacturers in 2015
Table Major Buyers of HIV Drugs
Table Distributors/Traders List
Figure United States HIV Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States HIV Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States HIV Drugs Production Forecast by Type (2017-2022)
Table United States HIV Drugs Consumption Forecast by Application (2017-2022)
Table United States HIV Drugs Sales Forecast by States (2017-2022)
Table United States HIV Drugs Sales Share Forecast by States (2017-2022)